New methods for analyzing solid samples using advanced spectroscopy techniques
Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy
This study is testing a new way to analyze important compounds in medicine using a technique that helps scientists better understand how different substances work, which could lead to improved treatments for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brightspec, INC. NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10805502 on NIH RePORTER |
What this research studies
This research focuses on developing a novel sampling technique called Laser Induced Acoustic Desorption (LIAD) for Molecular Rotational Resonance (MRR) spectroscopy. By improving how solid phase analytes are volatilized, this method aims to make a wider range of important compounds accessible for analysis. Patients may benefit from advancements in pharmaceutical development and better understanding of various health-related compounds. The research seeks to enhance the capabilities of MRR, which is known for its efficiency in determining the structure and quantity of small molecules.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in pharmaceutical treatments or those affected by conditions requiring precise molecular analysis.
Not a fit: Patients with conditions that do not involve small molecule analysis or those not engaged in pharmaceutical treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more cost-effective drug development and improved diagnostic techniques for patients.
How similar studies have performed: Other research has shown success with similar advanced spectroscopic techniques, indicating a promising potential for this novel approach.
Where this research is happening
Charlottesville, United States
- Brightspec, INC. — Charlottesville, United States (Active)
Researchers
- Principal investigator: Blagojevic, Voislav — Brightspec, INC.
- Study coordinator: Blagojevic, Voislav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.